Piperazine derivatives for binding and imaging amyloid plaques and their use

Details for Australian Patent Application No. 2009291251 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Schmitt-Willich, Heribert; Rohn, Ulrike; Friebe, Matthias; Lehmann, Lutz; Fitzner, Ansgar; Krause, Sabine; Brockschneider, Damian; Dyrks, Thomas; Thiele, Andreas; Bomer, Ulf; Monning, Ursula; Heinrich, Tobias

Agent Davies Collison Cave

Pub. Number AU-A-2009291251

PCT Pub. Number WO2010/028776

Priority 08164279.5 12.09.08 EP

Filing date 4 September 2009

Wipo publication date 18 March 2010

International Classifications

C07D 209/24 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 295/185 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/028776 Priority application(s): WO2010/028776

12 May 2011 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Bayer Schering Pharma Aktiengesellschaft, Application No. 2009291251, under INID (72) correct the co-inventor to Brockschnieder, Damian; under INID (72) correct the co-inventor to Thiele, Andrea

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009291254-Disinfecting device having power supply means and fluid outlet

2009291248-Retaining tab for standing-seam trays on wood or wood-derivative carriers